Amyotrophic lateral sclerosis: One or multiple causes?

Neurology International

Volumn 3, Issue 1, 2011, Pages 12-16

  Bastos, Aline Furtado ^a   Orsini, Marco ^b,c   Machado, Dionis ^d   Mello, Mariana Pimentel ^a   Nader, Sergio ^e   Silva, Julio Guilherme ^b,f   Catharino, da Antonio M Silva ^g   Freitas, Marcos R G ^b   Pereira, Alessandra ^c   Pessoa, Luciane Lacerda ^c   Sztajnbok, Flavio R ^c   Leite, Marco Araujo ^b   Nascimento, Osvaldo J M ^b   Bastos, Victor Hugo ^h  

^a Centro Universitario Serra Dos Orgaos   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Grande Rio University   (Brazil)

^d UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f Centro Universitario Augusto Motta   (Brazil)

^g Division of Oral and Maxillofacial Surgery   (Brazil)

^h Federal University of Valleys of Jequitinhonha and Mucuri   (Brazil)

Author keywords

Amyotrophic lateral sclerosis; Etiology; Hypothesis; Motor neuron disease; Neuromuscular diseases; Review

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ADULTHOOD; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DATA BASE; ENVIRONMENTAL FACTOR; GENE MUTATION; HEAVY METAL POISONING; HUMAN; INFORMATION RETRIEVAL; MEDLINE; MOTOR NEURON DISEASE; OCCUPATIONAL DISEASE; PHYSICAL ACTIVITY; QUALITY OF LIFE; VIRUS INFECTION;

EID: 80053073217     PISSN: 20358385     EISSN: 20358377     Source Type: Journal    
DOI: 10.4081/ni.2011.e4     Document Type: Article

References (59)

1. Rowland L P, Shneider NA. Amyotrophic Lateral Sclerosis. N Engl J Med 2001;22: 1688-700.
2. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009;4:3.
3. Rothstein JD. Current Hypotheses for the Underlying Biology of Amyotrophic Lateral Sclerosis. Ann Neurol 2009;65:S3-9.
4. Aguilar JLG, Echaniz-Laguna A, Fergani A, et al. Amyotrophic lateral sclerosis: all roads lead to Rome. Journal of Neurochemistry 2007;101:1153-60.
5. Brown-Jr RH, et al. Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrison's Principles of Internal Medicine. New York: McGraw Hill; 2008. p. 2572-576.
6. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-49.
7. Lacomblez L, Bensimon G, Leigh PN, et al. Dose-ranging study of riluzole in amy-otrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-31.
8. Oliveira ASB, Pereira RDB. Amyotrophic Lateral Sclerosis (ALS): Three letters that change the people's life for ever. Arq Neuropsiquiatr 2009;67:750-82.
9. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amy-otrophic lateral sclerosis. Nature 1993;362:59-62.
10. Cluskey S, Ramsden DB. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol Pathol 2001;54:386-92.
11. Wicklund MP. Amyotrophic Lateral Sclerosis: Possible Role of Environmental Influences. Neurol Clin 2005;23:461-84.
12. Orsini M, De Freitas MRG, Oliveira ASB, et al. Esclerosis lateral amiotrófica esporádi-ca de inicio juvenil. Rev Neurol 2010;50: 442-4.
13. Cozzolino M, Ferri A, Carrí MT. Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications. Antioxid Redox Signal 2008;10:405-43.
14. Brooks BR, Sanjak M. Disease-modifying drug therapies. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:68-75.
15. Richard OW, Russell JM, Ross M. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. ALS 2008;9:195-211.
16. Mitsumoto H, Chad DA, Pioro E P. Amyotrophic lateral sclerosis. Contempo -rary neurology series. Oxford University Press. edition 1; vol.49, 1998.
17. Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004;3:205-14.
18. Stanich P, Pereira AML, Chiappetta AL, et al. Suplementação nutricional em pacientes com doença do neurônio motor/ esclerose lateral amiotrófica. Rev Bras Nut Clin 2004;19:70-77.
19. Jackson C, Gronseth G, Rosenfeld J, et al. Randomized double-blind study of botu-linum toxin type B for sialorrhea in ALS patients. Muscle Nerve 2009;39:137-43.
20. Shaw CE, Enayat ZE, Chioza BA, et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998;43:390-4.
21. Kwiatkowski TJ, Bosco DA, LeClerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotroph-ic lateral sclerosis. Science 2009;323:1205-8.
22. Rademakers R, Stewart H, Dejesus-Hernandez M, et al. FUS Gene Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Muscle Nerve 2010;42: 170-6.
23. Harms MM, Miller TM, Baloh RH. TARDBP - Related Amyotrophic Sclerosis. GeneReviews. 2009;Apr 23 [updated 2009 May 28].
24. Kühnlein P, Sperfeld AD, Vanmassenhove B, et al. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol 2008;65:1185-9.
25. Mendonça DM, Martins SC, Higashi R, et al. Neurofilament heavy subunit in cere-brospinal fluid: a biomarker of amyotroph-ic lateral sclerosis. Amyotroph Lateral Scler 2011;12:144-7.
26. Haramati S, Chapnik E, Sztainberg Y, et al. MiRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci USA 2010;107:13111-6.
27. Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:235-50.
28. Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amy-otrophic lateral sclerosis. Neuroepide -miology 2003;22:217-28.
29. Banack SA, Murch SJ. Multiple neurotoxic items in the Chamorro diet link BMAA with ALS/PDC. Amyotroph Lateral Scler 2009;10:34-40.
30. Bradley WG, Mash DC. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler 2009;10: 7-20.
31. Sieh W, Choi Y, Chapman NH, Craig UK, et al. Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet 2009;18:3725-38.
32. Weisskopf MG, Morozova N, O'Reilly EJ, et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2009;80:558-61.
33. Plato CC, Garruto RM, Galasko D, et al. Amyotrophic lateral sclerosis and parkin-sonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003;157:149-57.
34. Waring SC, Esteban-Santillan C, Reed DM, et al. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 2004;23:192-200.
35. Steele JC, McGeer PL. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 2008;70:1984-90.
36. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007;369:2031-41.
37. Weisskopf MG, McCullough ML, Morozova N, et al. Prospective Study of Occupation and Amyotrophic Lateral Sclerosis Mortality. Am J Epidemiol 2005;162:1146-52.
38. Morahan JM, Pamphlett R. Amyotrophic Lateral Sclerosis and Exposure to Environmental Toxins: An Australian Case-Control Study. Neuroepidemiol 2006;27:130-5.
39. Weisskopf MG, McCullough ML, Calle EE, et al. Prospective Study of Cigarette Smoking and Amyotrophic Lateral Sclerosis. Am J Epidemiol 2004;160:26-33.
40. Fang F, Bellocco R, Hernán MA, Ye Weimin. Smoking, Snuff Dipping and the Risk of Amyotrophic Lateral Sclerosis - A Prospective Cohort Study. Neuroepide -miology 2006;27:217-21.
41. Sutedja NA, Veldink JH, Fischer K, et al. Lifetime occupation, education, smoking, and risk of ALS. Neurology 2007;69:1508-14.
42. Popat RA, Tanner CM, Van Den Eeden SK, et al. Effect of non-steroidal anti-inflammatory medications on the risk of amy-otrophic lateral sclerosis. Amyotroph Lateral Scler 2007;8:157-63.
43. Huynh W, Lam A, Vucic S, et al. Corticospinal tract dysfunction and development of amyotrophic lateral sclerosis following electrical injury. Muscle Nerve 2010;42:288-92.
44. Mitchell JD. Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin 1987;5:43-60.
45. Kamel F, Umbach DM, Munsat TL, et al. Lead Exposure and Amyotrophic Lateral Sclerosis. Epidemiology 2002;13:311-9.
46. Oh S, Kim EA, Lee S, et al. A case of amy-otrophic lateral sclerosis in electronic parts manufacturing worker exposed to lead. NeuroToxicology 2007;28:324-7.
47. Schwarz S, Husstedt IW, Bertram H P, Kuchelmeister K. Amyotrophic lateral sclerosis after accidental injection of mercury. J Neurol Neurosurg Psychiatry 1996;60:698.
48. Weihl CC, Lopate G. Motor Neuron Disease Associated with Copper Deficiency. Muscle Nerve 2006;34:789-93.
49. Vinceti M, Bonvicini F, Bergomi M, Malagoli C. Possible involvement of over-exposure to environmental selenium in the etiology of amyotrophic lateral sclerosis: a short review. Ann Ist Super Sanità 2010;46:279-83.
50. Ravits J. Sporadic amyotrophic lateral sclerosis: A hypothesis of persistent (nonlytic) enteroviral infection. Amyotroph Lateral Scler 2005;6:77-87.
51. Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sc 2006;240:59-64.
52. Berger MM, Kopp N, Vital C, et al. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 2000;54: 20-5.
53. Jubelt B, Berger JR. Does viral disease underlie ALS?: Lessons from the AIDS pandemic. Neurology 2001;57:945-6.
54. Zoccolella S, Carbonarab S, Minerva D, et al. A case of concomitant amyotrophic lateral sclerosis and HIV infection. European Journal of Neurology 2002;9:177-85.
55. Akhvlediani T, Kvirkvelia N, Shakarishvili R, Tsertsvadze T. ALS-like syndrome in the patient with chronic hepatitis C. Georgian Med News 2009;70-1.
56. Strickland D, Smith SA, Dolliff G, et al. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand 1996;94: 45-50.
57. Veldink JH, Kalmijn S, Groeneveld GJ, et al. Physical activity and the association with sporadic ALS. Neurology 2005; 64:241-5. 58.
58. Longstreth JrWT, McGuire V, Kopsell TD, et al. Risk of Amyotrophic Lateral Sclerosis and History of Physical Activity - A Population-Based Case-Control Study. Arch Neurol 1998;55:201-6.
59. Wicks P, Ganesalingham J, Collin C, et al. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007;8:177-9.